Atrial Fibrillation in Heart Failure: Prognostic Significance and Management

Gerald Naccarelli, B. John Hynes, Deborah Wolbrette, Luna Bhatta, Mazhar Khan, Soraya Samii, Jerry C. Luck

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm.

Original languageEnglish (US)
JournalJournal of Cardiovascular Electrophysiology
Volume14
Issue number12 SUPPL.
StatePublished - Dec 2003

Fingerprint

Atrial Fibrillation
Heart Failure
Angiotensin Receptor Antagonists
Anti-Arrhythmia Agents
Angiotensin-Converting Enzyme Inhibitors
Therapeutics
Hemodynamics
Maintenance
Survival

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology

Cite this

@article{a619e96632a6455db0bf41048def4f2f,
title = "Atrial Fibrillation in Heart Failure: Prognostic Significance and Management",
abstract = "Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm.",
author = "Gerald Naccarelli and Hynes, {B. John} and Deborah Wolbrette and Luna Bhatta and Mazhar Khan and Soraya Samii and Luck, {Jerry C.}",
year = "2003",
month = "12",
language = "English (US)",
volume = "14",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "12 SUPPL.",

}

Atrial Fibrillation in Heart Failure : Prognostic Significance and Management. / Naccarelli, Gerald; Hynes, B. John; Wolbrette, Deborah; Bhatta, Luna; Khan, Mazhar; Samii, Soraya; Luck, Jerry C.

In: Journal of Cardiovascular Electrophysiology, Vol. 14, No. 12 SUPPL., 12.2003.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Atrial Fibrillation in Heart Failure

T2 - Prognostic Significance and Management

AU - Naccarelli, Gerald

AU - Hynes, B. John

AU - Wolbrette, Deborah

AU - Bhatta, Luna

AU - Khan, Mazhar

AU - Samii, Soraya

AU - Luck, Jerry C.

PY - 2003/12

Y1 - 2003/12

N2 - Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm.

AB - Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm.

UR - http://www.scopus.com/inward/record.url?scp=0347023039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347023039&partnerID=8YFLogxK

M3 - Article

C2 - 15005215

AN - SCOPUS:0347023039

VL - 14

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 12 SUPPL.

ER -